Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?
CONCLUSION: Clinical studies on sh-oligopeptide-1 have no scientific basis, as the preclinical bioactivity of this molecule has not been proven.PMID:37452558 | DOI:10.1080/15569527.2023.2234020 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 15, 2023 Category: Toxicology Authors: Pedro A Mart ínez-Carpio Source Type: research
Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?
CONCLUSION: Clinical studies on sh-oligopeptide-1 have no scientific basis, as the preclinical bioactivity of this molecule has not been proven.PMID:37452558 | DOI:10.1080/15569527.2023.2234020 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 15, 2023 Category: Toxicology Authors: Pedro A Mart ínez-Carpio Source Type: research
Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?
CONCLUSION: Clinical studies on sh-oligopeptide-1 have no scientific basis, as the preclinical bioactivity of this molecule has not been proven.PMID:37452558 | DOI:10.1080/15569527.2023.2234020 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 15, 2023 Category: Toxicology Authors: Pedro A Mart ínez-Carpio Source Type: research
Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?
CONCLUSION: Clinical studies on sh-oligopeptide-1 have no scientific basis, as the preclinical bioactivity of this molecule has not been proven.PMID:37452558 | DOI:10.1080/15569527.2023.2234020 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 15, 2023 Category: Toxicology Authors: Pedro A Mart ínez-Carpio Source Type: research
Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?
CONCLUSION: Clinical studies on sh-oligopeptide-1 have no scientific basis, as the preclinical bioactivity of this molecule has not been proven.PMID:37452558 | DOI:10.1080/15569527.2023.2234020 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 15, 2023 Category: Toxicology Authors: Pedro A Mart ínez-Carpio Source Type: research
Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?
CONCLUSION: Clinical studies on sh-oligopeptide-1 have no scientific basis, as the preclinical bioactivity of this molecule has not been proven.PMID:37452558 | DOI:10.1080/15569527.2023.2234020 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 15, 2023 Category: Toxicology Authors: Pedro A Mart ínez-Carpio Source Type: research
Mucocutaneous alterations and complications in amphetamine abusers: A narrative review
Cutan Ocul Toxicol. 2023 Jul 14:1-23. doi: 10.1080/15569527.2023.2235425. Online ahead of print.ABSTRACTAmphetamines are the second most commonly used illicit drug worldwide. Amphetamine use can result in significant cutaneous morbidity. This review highlights the dermatological manifestations of amphetamine abuse.PMID:37450708 | DOI:10.1080/15569527.2023.2235425 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 14, 2023 Category: Toxicology Authors: Mahdi Balali-Mood Rodney D Sinclair Emadodin Darchini-Maragheh Leila Etemad Source Type: research
Evaluation of Choroidal Thickness and Choroidal Vascular Index in Patients Using Combined Oral Contraceptive Pills
CONCLUSION: To our knowledge, this is the first study to evaluate CVI in women using COCp, and CVI was found to be lower in individuals using COCp. Therefore, CVI can be used in the follow-up of possible ocular pathologies that may develop in individuals using COCp.PMID:37437218 | DOI:10.1080/15569527.2023.2235429 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 12, 2023 Category: Toxicology Authors: Mehmet Icoz Sema Yuzbasioglu Source Type: research
Evaluation of Choroidal Thickness and Choroidal Vascular Index in Patients Using Combined Oral Contraceptive Pills
CONCLUSION: To our knowledge, this is the first study to evaluate CVI in women using COCp, and CVI was found to be lower in individuals using COCp. Therefore, CVI can be used in the follow-up of possible ocular pathologies that may develop in individuals using COCp.PMID:37437218 | DOI:10.1080/15569527.2023.2235429 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 12, 2023 Category: Toxicology Authors: Mehmet Icoz Sema Yuzbasioglu Source Type: research
Evaluation of Choroidal Thickness and Choroidal Vascular Index in Patients Using Combined Oral Contraceptive Pills
CONCLUSION: To our knowledge, this is the first study to evaluate CVI in women using COCp, and CVI was found to be lower in individuals using COCp. Therefore, CVI can be used in the follow-up of possible ocular pathologies that may develop in individuals using COCp.PMID:37437218 | DOI:10.1080/15569527.2023.2235429 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 12, 2023 Category: Toxicology Authors: Mehmet Icoz Sema Yuzbasioglu Source Type: research
Investigating the effects of dermal exposure to < em > in-vivo < /em > animal models on the riot-control properties of a powder formulation of < em > Tragia involucrata < /em > leaf hair lining
Conclusion: The preclinical results did not produce any indication of severe toxicity which supports it to be used as a natural RCAs in the future.PMID:37427420 | DOI:10.1080/15569527.2023.2227255 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 10, 2023 Category: Toxicology Authors: Trishna Mani Nath Sanghita Das None Zothanpuia Pronobesh Chattopadhyay Source Type: research
Investigating the effects of dermal exposure to < em > in-vivo < /em > animal models on the riot-control properties of a powder formulation of < em > Tragia involucrata < /em > leaf hair lining
Conclusion: The preclinical results did not produce any indication of severe toxicity which supports it to be used as a natural RCAs in the future.PMID:37427420 | DOI:10.1080/15569527.2023.2227255 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 10, 2023 Category: Toxicology Authors: Trishna Mani Nath Sanghita Das None Zothanpuia Pronobesh Chattopadhyay Source Type: research
Effect of Smoking on Corneal and Lens Clarity: A Densitometric Analysis
CONCLUSION: Lens densitometry measurements of smokers were significantly increased while corneal densitometry measurements were not significantly altered compared to non-smokers. Smoking may contribute to cataroctogenesis and smoking and age-related changes may act synergistically to cataract development among smokers.PMID:37417933 | DOI:10.1080/15569527.2023.2234023 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 7, 2023 Category: Toxicology Authors: Delil Özcan Source Type: research
Aging of The Skin In Pseudoexfoliation Syndrome
CONCLUSION: These results implies that there is quicker progression in aging of facial skin in PES than normals.PMID:37417936 | DOI:10.1080/15569527.2023.2234024 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 7, 2023 Category: Toxicology Authors: Hakan Cinal Halil İbrahim Yener Source Type: research
Early effects of intravitreal anti-VEGF agents on cornea and visual acuity in patients with diabetic retinopathy
CONCLUSION: Intravitreal administration of anti-VEGF agents could cause a small but significant greater increase in CCT in PDR than in NPDR eyes in the early period. In patients with DR, no significant difference was found between conbercept and ranibizumab in the early effects on the visual acuity nor in the cornea.PMID:37417939 | DOI:10.1080/15569527.2023.2234036 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - July 7, 2023 Category: Toxicology Authors: Xuanli Liu Wei Shen Wei Xia Peirong Lu Source Type: research
